Daily Digest — September 12, 2026

Just filed

FutureCore Acquisition Corp

No ticker yet · Initial S-1 · Up to $75 million · Nasdaq

FutureCore is a blank-check company — a SPAC — seeking to raise $75 million through an offering of 7,500,000 units at $10.00 per unit, with $10.025 per unit flowing into trust. The stated hunting ground is veterinary and animal health: the sole officer — who holds Chairman, CEO, and CFO titles simultaneously and owns 100% of the sponsor — brings a background that includes overseeing roughly $200 million in revenue across 170 Banfield locations and taking Inspire Veterinary Partners public at a $40 million valuation after raising $18 million across 14 locations in 10 states.

The structural picture is where the filing demands close reading. The sponsor acquired 4,312,500 founder shares for $25,000 — a price of roughly $0.006 per share — giving insiders 33.33% of post-IPO shares at a cost that public buyers cannot replicate. Two named peer SPACs (FortuneX and Futurewave) each raised $75 million at the same $10 unit price and share the same target enterprise value range of $180 million to $1 billion — meaning FutureCore is fishing in exactly the same pond as its disclosed affiliates, with no contractual priority in the prospectus over which vehicle gets first look at any deal. The combination window is 15 months from closing, and heavy redemptions compress the math sharply: net tangible book value per share falls to $3.90 at partial redemption and to $0.12 at maximum redemption.

The veterinary thesis is real. The deal-allocation question is not answered in the prospectus.